Xcopri 200 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FQZAY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,324
Award facts
- Contract value 100% obligated
- $1,323.89 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for XCOPRI 200 mg tablets (30-count units) on July 18, 2025, with a ceiling value of $1,323.89 and an ultimate completion date of July 21, 2025. This is a firm fixed price, non-competitive delivery order with no set-aside designation. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and serves as a critical federal medical procurement vendor for military and veteran healthcare systems.
This delivery order represents a continuation of AmerisourceBergen's extensive portfolio of pharmaceutical deliveries under the DLA Medical Supply Chain, which encompasses a wide spectrum of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The company's consistent receipt of competitively awarded delivery orders with firm fixed pricing demonstrates its capability to meet federal procurement requirements and serve customers including the Defense Health Agency and U.S. Coast Guard. The pharmaceutical supply through this and related contracts supports military healthcare operations globally.
Quick answers
Who was awarded contract SPE2DB25FQZAY?
SPE2DB25FQZAY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 18, 2025.
How much is contract SPE2DB25FQZAY worth?
The government has obligated $1,324 on SPE2DB25FQZAY.
Is contract SPE2DB25FQZAY an order under another contract?
Yes. SPE2DB25FQZAY is a delivery order under SPE2DB25D3021, an indefinite delivery contract.
Was contract SPE2DB25FQZAY competed?
The extent of competition for SPE2DB25FQZAY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award